Attenuating the effects of novel COVID-19 (SARS-CoV-2) infection-induced cytokine storm and the implications
AB Rowaiye, OA Okpalefe… - Journal of …, 2021 - Taylor & Francis
The COVID-19 pandemic constitutes an arduous global health challenge, and the
increasing number of fatalities calls for the speedy pursuit of a remedy. This review …
increasing number of fatalities calls for the speedy pursuit of a remedy. This review …
[HTML][HTML] COVID-19 in joint ageing and osteoarthritis: current status and perspectives
COVID-19 is a trending topic worldwide due to its immense impact on society. Recent trends
have shifted from acute effects towards the long-term morbidity of COVID-19. In this review …
have shifted from acute effects towards the long-term morbidity of COVID-19. In this review …
[HTML][HTML] Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter …
AA Rabaan, SH Al-Ahmed, MA Garout, AM Al-Qaaneh… - Pathogens, 2021 - mdpi.com
The pathogenesis of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is still not fully unraveled. Though …
respiratory syndrome coronavirus 2 (SARS-CoV-2), is still not fully unraveled. Though …
[HTML][HTML] Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study
A Balkhair, I Al-Zakwani, M Al Busaidi… - International Journal of …, 2021 - Elsevier
Objective The aim of this study was to evaluate the efficacy of anakinra in patients who were
admitted to hospital for severe COVID-19 pneumonia requiring oxygen therapy. Methods A …
admitted to hospital for severe COVID-19 pneumonia requiring oxygen therapy. Methods A …
[HTML][HTML] SARS-CoV-2 spike glycoprotein S1 induces neuroinflammation in BV-2 microglia
OA Olajide, VU Iwuanyanwu, OD Adegbola… - Molecular …, 2022 - Springer
In addition to respiratory complications produced by SARS‐CoV‐2, accumulating evidence
suggests that some neurological symptoms are associated with the disease caused by this …
suggests that some neurological symptoms are associated with the disease caused by this …
[HTML][HTML] Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
C Lee, WJ Choi - Archives of pharmacal research, 2021 - Springer
The novel beta coronavirus (SARS-CoV-2, designated as COVID-19) that is responsible for
severe acute respiratory syndrome has devastated the global economy and health care …
severe acute respiratory syndrome has devastated the global economy and health care …
[HTML][HTML] Hyperinflammatory response in COVID-19: a systematic review
MJA Silva, LR Ribeiro, MIM Gouveia, BR Marcelino… - Viruses, 2023 - mdpi.com
COVID-19 is a multisystemic disease caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). The immunopathogenic conditions of the hyperinflammatory …
coronavirus 2 (SARS-CoV-2). The immunopathogenic conditions of the hyperinflammatory …
[HTML][HTML] Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: experience from Bangladesh
Background The hematological abnormalities are assumed to be involved in the disease
progression of COVID-19. However, the actual associations between specific blood …
progression of COVID-19. However, the actual associations between specific blood …
[HTML][HTML] The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19
S Makaremi, A Asgarzadeh, H Kianfar… - Inflammation …, 2022 - Springer
A global pandemic has erupted as a result of the new brand coronavirus, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). This pandemic has been consociated …
respiratory syndrome coronavirus 2 (SARS-CoV-2). This pandemic has been consociated …
[HTML][HTML] Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19
L Chen, Q Huang, T Zhao, L Sui, S Wang, Z Xiao… - Redox Biology, 2021 - Elsevier
SARS-CoV-2 has caused up to 127 million cases of COVID-19. Approximately 5% of COVID-
19 patients develop severe illness, and approximately 40% of those with severe illness …
19 patients develop severe illness, and approximately 40% of those with severe illness …